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SOON after the discovery of the carcinogenic activity of 1:2:5:6-dibenzan-
thracene by Cook, Kennaway and colleagues, Yoshida (1932, 1933, 1934) and
Sasaki and Yoshida (1935) reported that the addition of o-aminoazotoluene to
the food leads to the production ofmalignant liver tumours in rats. During the
past two decades scores ofother azo- compounds have beentested forcarcinogenic
activity of this type and many have been shown to be active. For reviews see
Shear (1937), Kinosita (1937), Cook (1939, 1943, 1948), Cook and Kennaway
(1938).
These carcinogenic azo- compounds form a very interesting group. Unhke
the polycyclic aromatic hydrocarbons, they do not, as a rule, produce tumours
at the site ofinjection, but mostly affect the liver. Furthermore, the induction
ofliver tumours with azo- compounds is markedl influenced bv the dieb, and if a y .1
cc protective
" diet issupplied, theproduction oftumours can be stronglyinhibited
or even entirely prevented.
All the azo- compounds are, of course, artificial synthetic substances ; and
they are highly coloured (mainly orange to red). Some are used as textile dye- stuffs, and certain members of the group are used for colouring foodstuffs. For
the most part such compounds are probably harmless (Cook, 1948). Most ofthe
food-colouring matters which have been tested have failed to induce liver tumours
in rats; and in any case it is most unlikely that anyone could ever consume
enough of an azo- compound in food to have any deleterious effect. Nevertheless
the risk remains, a risk which has recently been underlined by the report that
benzeneazo-,8-naphthol is ahepatotropic carcinogen wheninjectedsubcutaneously in mice (Kirby and Peacock, 1949).
It has also been suggested that azo- compounds may be responsible for some
of the occupational cancers which are found among workers in the dyestuffs industry, and this is a problem which still requires further investigation.
The study of the azo- compounds is of importance in any research into the
process and mechanism of carcinogenesis. This review is an attempt to assess
the present position in the study oftherelationship between chemical constitution
and carcinogenic activity in this series.
Hi8torical.
In 1906 Fischer described the atv-pical epithelial proliferation which resulted
following the injection of a solution--of scarlet red J; also known as Biebrich
scarlet R medicinal) into the ears of rabbits. The growths always receded and271 THE CARCINOGENIC AZO- COMPOUNDS
never 'became malignant ; nevertheless, this was the first recorded instance of
the production of a tumour-like proliferation by a pure chemical compound of
any type. At Fischer's suggestion, scarlet red soon came into use to accelerate
woundhealing.
Not long afterwards it wag found that the active part of the molecule is
o-aminoazotoluene JI), also known as 4'-amino-2:3'-azotoluene, as 2':3-dimethyl-
4-aminoazobenzene (IIa), and as 2-amino-5-azotoluene (IM). This compound
was found to bave an effect on epit-hehal cells similar to that ofscarlet red, and it
was likewise effective in accelerating healing (Hayward, 1909 ; Stijber, 1909).
CH CH CH3 CH 3 3 3
N=N NHZ N=N NH2
(Ila) (Ilb)
Malignant liver tumours in rats were first produced with this compound by Yoshida (1932, 1933, 1934) and Sasaki and Yoshida (1935), who administered it
by addition to the food. Soon afterwards Shear (1937) found that subcutaneous
implantation of the pure solid in pure strain mice also gave transplantable liver-
eelI carcinomas; but no tumours were produced at the site ofinjection. The carcinogenic activity of o-aminoazotoluene to the livers of mice and rats
has been confirmed many times under a variety of experimental conditions
(Hartwell, 1941). To some extent the compound is also carcinogenic towards
the bladder (Yoshida, 1935), and it is interesting that the deaminated compound, namely 2:3'-azotoluene (III), was found to be non-carcinogenic to the liver ofthe
rat, but produced numerous papillomas in the bladder (Otsuka andNagao, 1936). Many derivatives of azobenzene, containing substituent amino- and methyl-
groups, were tested for carcinogenic activity by Kinosita (1937). None of these
produced cancer of the liver except o-aminoazotoluene, its mono-acetyl- and
diacetyl- derivatives, and an isomer of o-aminoazotoluene, namely 4-dimethyl- aminoazobenzene (IV). The latter compound, which is also known as p-di- methylaminoazobenzene, and asN,N-dimethyl-p-aminoazobenzene, wasformerly used as afood-colouring matter under the name of
"butteryellow". It was found
to be even more active towards rat-liver than o-aminoazotoluene, producing a
higher percentage of tumours in a shorter time; but it has since been shown that
therelativeactivities arereversedin mice (Law, 1941 ; Kirby, 1945). 4-Dimethyl- aminoazobenzenehasbeen moreextensivelystudiedthan an other azo-compound y and its carcinogenic activity has been widely confirmed (Hartwell, 1941).' The parent compound, 4-aminoazobenzene (V), has usually failed to produce liver tumours (Miller and MiRer, 1948); but Kirby (1944, 1947; Kirby and272 G. M. BADGER AND G. E. LEWIS
Peacock, 1947) has obtained tumours of the liver in rats in experiments of very
long duration. Liver tumours have not, however, been produced in mice with
this compound (Sasaki and Yoshida, 1935; Kirby, 1945).
CH3 CH3
=N N(CH3) N=N NH,2 2
IY v
In recent years carcinogenic activity has been demonstrated in various
derivatives of 4-dimethvlaminoazobenzene, containing methyl-, fluoro-, chloro-,
nitro- and other substituent groups. The effects of such structural alterations
are described in afollowing section.
Most ofthe known carcinogenic azo- compounds are derivatives of4-dimethyl-
aminoazobenzene, or at least of 4-aminoazobenzene. Nevertheless, a 4-amino-
group is not essential for activity ofthis type. This was shown for example, by
Cook, Hewett, Kennaway and Kennaway (1940), who examined the action of
azonaphthalenes on mice. The compounds were administered by subcutaneous
iAiection,bypainting ontheskin, orbyadditiontothefood. Manvlivertumours,
mostly ofthe type ofcholangioma, were obtained with 2:2'-azonaphthalene (VI),
and a few tumours were obtained with 1:1'-azonaphthalene (VII). No carcino-
genic activity was, however, shown by 1:2'-azonaphthalene (VIII) or by its
4-amino- derivative.
N=N
N=N
RelativePotency ofCarcinogenic Azo- Compound&
The carcinogenic azo- compounds vary considerably in potency as measured
by the number of animals contracting the disease and tlle time taken to induce
the tumours. However, it is difficult to assess the relative potencies with any
degree ofaccuracy. Such difficulties are inherent in allbiological assays, and are
severelyaggravated when oine has to consider results obtained in several different
laboratories, under different experimental conditions.
Rats have been most generaUy used in this work; but, mice have also been
employed extensively, and tests have somebimes been carried out with other
laboratory animals. Sometimes the azo- compound has been injected subcu-
taneously; in other cases it has been administered in solution per 08 ; in
very many experiments it has been administered by mixing with the food.
As a matter of fact the latter method has been very widely used ; but it can
hardly be considered very satisfactory for the evaluation of relative potencies.
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structure can have a marked effect on the palatability of the food-mixture,
leading to marked variations in the total food intake, and hence the amount of
azo-dye consumed.
So far, the most ambitious attempt to assess the relative potencies of carcino-
genic azo- compounds has been that ofMiller and Miller (1948), who have carried
out a number of careful experiments in which the various compounds were added
to the food in quantities equivalent. (on a molecular weight basis) to 0-06 per cent
of4-dimethylaminoazobenzene.
Under the conditions used, 4-climethylaminoazobenzene gave a tumour
incidence of 70-92 per cent in rats after 4 months, and 100 per cent after 6 months.
This.compound was assigned an arbitrary relative potency of
" 6," and the
relative activities of otber compounds assessed by the formula :
Relative activity = 6 x 4 x per cent tumours with test compound
Months fed x per cent tumours with 4-diniethylamino-
azobenzene.
Compounds having relative potencies from ca. 1 to ca. 12 have been reported.
All compounds have not been examined under these conditions, however,
and it would be quite impossible to assign a relative activity value of this type
to every compound in the literatur'e ; something simpler is clearly required.
In these circumstances 4-dimethylaminoazobenzene has been t'aken as the
standard compound having
" moderate
" carcinogenic activity in the rat, and has
been given the grading ++. Compounds having approximately equivalent
carcinogenic activity have been given the same grading. Compounds having
carcinogenic activity markedly greater than that of 4-dimethylaminoazobenzene
in the rat have been graded +++ ; and similarly, compounds having less
activity have been graded +. The symbol ± has been used for compounds
exhibiting only traceactivity, or activity which can only be demonstrated under
veryspecialdietaryconditions. Thesymbol o has been usedfor thosecompounds which have not produced cancers of the liver; but it must be remembered that
many compounds given this grade are capable ofproducing other liver changes of a less serious nature.
The system adopted can best be appreciated by a study of Table 1, which
includes the relativepotency values ofMiller and Miller (1948).
TABLF, I.-Relative, Potencie8 ofCarcinogenic Azo- Compound8 to the Liver8
ofRat8.
Per cent tumour incidence at Relative potency.
3 4 6 8 lo+ ilier
months. montlis. months. months. months. and This
Miller. paper- W-Methyl-4-dimethylamino-
azobenzene 30 88a 10-12a +++ 4-Dimethylaminoazobenzone 0 70-92a 1008, 6& + + 2'-Methyl-4-dimethylamino-
szobenzone 44b 2-3c + o-Aminoazotoluene 30d Oc + 4-Aminoazobenzene 0 0 0 Oa 44o Oa
a, Miller and Miller, 1948. b, Miller and Baumarm, 1945b. c, Miller, Sapp and Miller, 1949.
d, Crabtree, 1949. e, Kirby, 1944, 1947.-974 G. M. BADGER AND G. E. LEWIS
The same relative potencies do not always apply in other laborat-ory animals.
It is well known, for example, that 4-dimethylaminoazobenzene is much less
active in producing'hver tumours in mice than it is in rats. On the other hand,
o-aminoazotoluene is much more effective in mice than in rats. The latter
compound is therefore taken as the standard for the assessment of relative
potencies in mice, and is assigned.a, grade of ++ for this species. In al-I other
respects the system adopted is similar to that for rats.
The, Carcinogenic Azo- Compounds.
(i) The aminoazo-toluene8.
Malignantliver tumours in rats were firstproducedwith4-amino-2':3-dimethyl-
azobenzene or o-aminoazotoluene (IX), and this compound has always retained
a prominent place in experimental carcinogenesis. In mice it is even more
effective, and it seems to be the most potent of all the azo- compounds for this
species. In addition, Law (1941) has reported that it produces sarcomas at the
site ofinjection in susceptible strains of mice.
CH3 CH3 CH3 3
N=N NRZ N=N
NH (ix) (X) 2
(o-aminoazotoluene) I
CH3
CH3 N=N NH2
(XI)
CH3 CH3
CH3 N=N NH2 CH3 N=N
(xai) ( ) NH-2
The structural isomers of this compound are of considerable interest. Six
isomers have been examined by Crabtree (1949) under comparable conditions.
Only two, 4-amino-2':3-dimethylazobenzene (IX, 4'-amino-2:3 -azotoluene or
o-aminoazotoluene) and 2-amino-2':5-dimethylazobenzene (X, 2'-amino-2:5'-
azotoluene) induced liver tumours in rats. In mice, however, malignant hepa-
tomas were produced by 4-amino-2':3-dimethylazobenzene (IX), by 2-amino-2':5-
climethylazobenzene (X) and also by 4-amino-2:4'-dimethylazobenzene (XI,
I -n by the 4 4 -amino-2':4-azotoluene). Slight activity was show -amino-2:3'-
dimethyl- and4-amino-3:4'-dimethyl- azobenzenes (XII and XIII) ; but 2-amino-
4':5-dimethylazobenzene (XIV) proved to be innocuous (Table II).
The positions of the substituent groups are therefore of considerable impor-
tance ; but it is clear that an amino- group in the 4-position is not essential for
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TABLE II.-Aminoazo-toluene8.
1 31 '2 2 3
40 N=N 4
5 6 6 5
Carcir
r
-R.j:Lf.Q- 'R.AfArAnpr
nogenic activity.
A
.os. Mice. References.
+ + a
+ + ab
+ + a
a
Compound.
-nnium. xwloroLlct
4-Amino-2':3-dimothylazobenzene, + a
2-Amino-2':5-dimethylazobenzone + a
4-Amino-2:4'-dimethylazobenzene 0 a
4-Amino-2:3'-dimethylazobenzene 0 a
4-Amino-3:4'-dimethylazobenzene 0 a
2-Amino-4':5-dimethylazobenzone 0 a
a, Crabtree, 1949. b, Kirby, 1945.
0
a
a
(ii) Subdituted azobenzenes.
Azobenzene itself seems to be entirely inactive as a carcinogen; but activity
of various kinds has been demonstrated for many derivatives (Table 111).
4-Hydroxyazobenzene (XV) produced papillomas in the stomach in rats, and
4-hydroxy-2':3-dimethylazobenzene (XVI) gave papillomas of the bladder. The
latter compound has also produced a number of sarcomas at the site ofinjection
in susceptible strains of mice; moreover it seems to have shght activity on the
liver ofthis species (Law, 1941 ; Kirby, 1945). On the otherhand, 4-cWoro-2':3-
dimethylazobenzene seems to be, inactive, at least in mice. Theparent dimethyl-
compound, 2':3-dimethylazobenzene (XVII, commonly know-n as 2:3'-azotoluene),
produced bladder papillomas when fed to rats in a rice diet (Otsuka and Nagao,
1936) ; but it does seem to be inactive towards the liver (Kirby, 1945). Law has
also reported that it produces sarcomag at the site of injection in susceptible
strains of mice.
Kinosita's discovery (1937) that 4-dimethylaminoazobenzene (XVIII) is even
more potent in producing liver tumours in rats than o-aminoazotoluene has
tended to concentrate attention on the 4-amino- and 4-alkylamino- derivatives
ofazobenzene, so that very little is known about the effect of other substituents.
As already mentioned, o-aminoazotoluene is a liver carcinogen both for rats
and mice, and its monoacetyl- and diacetyl- derivatives have also produced liver
tumours in mice.
CHS CH3
N-N OH
Na---N N(CH3),Z
(xvm)
N =--N OH
(xv)
CH3 CH3
N=N
(xim)
4-Aminoazobenzene seems to have trace activity in the rat, and derivatives
having methyl- substituents iri the other ring are also either ineffective or only276 G. M. BADGER AND G. E. LEWIS
slightly active. 4-Methylamino- and4-dimethylamino-azobenzenes are, however,
moderatelypobentcarcinogens to rat liver. As a matter offact it is notsurprising
that these compounds are approximately equally effective (Giese, MiRer and
Baumann, 1945), because MiHer, Afiller and Baumann (1945) have show-n that
4-dimethylaminoazobenzene is partiaRy demethylated in vivo, and also that
4-methylaminoazobenzene ispartiallymethylated. (4-Aminoazobenzene, however,
was not methylated.)
The higher N, N-dialkyl derivatives all seem to be ineffective as carcinogens
(Sugiura, Halter, Kensler and Rhoads, 1945), although 4-diethylaminoazobenzene
has also been show-n to be dealkylated to 4-aminoazobenzene in rats (Kensler,
Magill, Sugiura and Rhoads, 1946).
TABLE III.-Substituted Azobenzenes.
31 21- 2 3
4! N =--N 4
51 6 6 5
Carcinogenic activity.
Compound.
Rats. References. Mice. References.
Azobenzene 0 a 0 a
4-Hydroxy- 0 a
*4-Amino- bc 0
4-Methylamino- ++ cdo
t4-Dimethylamino- ++ abcde +
4-Mothylethylamino- ++ fi
4-Diethylamino- 0 d 0 b
4-Di-n-propylamino- 0 d
4-Di-n-butylamino- 0 d
4-Di-n-amylamino- 0 d
4-Phenylazo- 0 a
2:4-Diamino- 0 a
2:4-Dismono-5-methyl- 0 a
2:4-Diamino-2':5-dimethyl- 0 a
4'-Mothyl-4-amino- + d
2"-Methyl-4-methylamino- + f
3-'-Mothyl-4-methylamino- + + + fi
4'-Methyl-4-methylamino- + f
2:2:4':5-Tetramethyl-4-amino- 0 a
2':3':4":5":6'-Pentamethyl-4-amino- 0 d
§2-':3-Dimethyl- 02 a
4-Chloro-2':3-dimethyl- 0 a
4-Hydroxy-2':3-dimethyl- 02 a h
4-Acetoxy-2':3-dimethyl- 0 a
T4-Amino-2':3-dimethyl- + ak ++ ahklm
4-Acetylamino-2':3-dimethyl- + a
4-Diacetylamino-2':3-dimethyl- + a
*, i.e.,p-aminoazobenzene. t,i.e.,p-dimethylaminoazobenzene. §j.e.,2:3--dimethy1&zobenzene
or 2:3'-azotoluene. T, i.e., o-aminoazotoluene.
1 2 Papillomasofthestomach. 'Papillomasofthebladdder.
a, Hartwell, 1941. b, Kirby, 1944 ; 1947 ; Kirby and Peacock, 1947. c, Miller and Baumaim,
1945b. d, Sugiura, Halter, Kensler and Rhoads, 1945. e, Giese, Miller and Baummm, 1945. f,
Sugiura, 1948. g, Kinosita, 1937, h, Law, 1941. i, Kirby, 1945. j, Mller and Miller, 1948.
k, Crabtree, 1949. 1, Shear 1937. m, Andervont, 1947.277 THE CARClNOGENIC AZO- COMPOVNDS
The effect of substituents on' the 4-dimethylaminoazobenzene molecule is
considered in the next section; but reference may be made at this stage to the
effect of substituents on 4-methylaminoazobenzene. The 2'- and 4'-methyl-
derivatives are 1e88 effective than the parent amine; but the 3'- derivative is a
potent carcinogen (Sugiura, 1945).
(iii) Sub8tituted 4-dimethylaminoazobenzene&
The pronounced activity of 4-dimethylaminoazobenzenes on the livers of
rats has led to the preparation and testing of numerous'derivatives of this com-
pound (Table IV). These derivatives fall into two main classes.
TABLEIV.-Sub8tituted 4-dimethylaminoazobenzene&
31 21 2 3
4/ N =--N N(CH3)-2
5' 6' 6 5
Carcinogenic activity.
A --"% R.ts. References.
+ + - ab
0 bd
0 9,b
0 b
+ + + .0
0 b
+ bd
+ ab
+ ab
+ + b
0 b
+ c
Compound.
4-Dimethylaminoazobenzene
2-Methyl-
3-Methyl-
2-Hydroxy-
2-Fluoro-
2'-Hydroxy-
T-Methyl-
2'-Nitro-
2'-Cloro-
2'-Fluoro-
2'-Trifluoromethyl-
*2'-Carboxy-
3'-Hydroxy-
3'-Methyl-
3'-Nitro
3'-Chloro- .
3'-Fluror-
3'-Trifluoromethyl-
3'-Ethoxy-
4'-Hydroxy-
4'-Methyl-
4'-Nitro
4'-Chloro- .
4'-Fluoro-
C-Trifluoromet-hyl-
4'-Arsonic acid
t4'-Sulphonic acid, sodium salt
2':4'-Difluoro-
2':4':6'-Trifluoro-
2':4':6'-Trichloro-
2':4':6'-Tribromo-
3':5'-Dimethyl-
2':5-Dimethyl-
2':4'-Dimethyl-
Methylred. t,Methylorange.
a, MiRer and 3LIler, 1948. b, Miller, Sapp and Miller,
Baumaim, 1945b. e, Miller, Miller and Sapp, 1951.
20
b
abd
ab
ab
b
b
a
b
bd
b
ab
b
b
c
c
e
e
b
b
a
a
a
0
0
0
0
0
0
0
0
0
0
0
0
1949. c, Hartwell, 1941. d, Mller and278 G. M. BADGER AND G. E. LEWIS
Inthefirst, theadditionalsubstituent is onthe samering asthedimethylamino-
group. Only a few such compounds have been tested, but, with the exception
ofthe 2-fluoro- compound, all have been found to be inactive.
In the second class the additional substituent is attached to the other benzene
ring. With the exception of the 2'-hydroxy- and 2'-trifluoromethyl- derivatives
which are entirely inactive, the ortho- or 2'- substituted 4-dimethylaminoazo-
benzenes are all less active than the parent compound. Only the 2'-fluoro-
derivative has about the same activity.
Among the meta- or 3'- substituted compounds, the hydroxy- and trifluoro-
methyl- derivatives areagain inactive ; theethoxy- derivative has traceactivity ;
the nitro- and chloro- derivatives have approximately the same activity as the
parent amine; and the 3'-methyl- and 3'-fluoro- derivatives are considerably
more effective in producing liver tumours than the unsubstituted 4-dimethyl-
aminoazobenzene.
The para- or 4 substituted derivatives are mostly inactive, or only very
slightly active; but the 4'-fluoro- derivative is more effective than 4-dimethyl-
aminoazobenzone itself. The 4'-meth
- and 4'-chloro- compounds are onl
slightly active, and the 4'-hydroxy-, 4'-nitro-, 4'-trifluoromethyl- and 4'-sul-
phonic acid derivatives are all completely inactive.
Relatively few di- and tri- substituted derivatives have been tested. It is
of some interest, however, that the 3':5'-dimethyl- derivative seems to be inactive
(in spite of the fact that mono-methyl substitu-Gion at these positions incrw8m
the potency). Other dimethyl- derivatives are also inactive; -so are the 2':4':6-
trichloro- and 2':4,':6'-tribomo- compounds.
(iv) Phenylazonaphthalene8and azonaphthalene8.
Many commercial dyestuffs and food-colouring matters fafl into this group.
Many of these are sulphonic acid derivatives, which are probably excreted too
rapidly to be effective as carcinogens; but some are simple hydroxy- or amino-
derivatives. Among-these, special interest attaches to 1-benzeneazo-2-naphthol
(XIX), which is a food-colouring matter and which Kirby and Peacock (1949)
haveshown to be alivercarcinogenin mice. Verycloselyrelatedtothissubstance
are Sudan 11, Sudan III, and scarlet red, substances which were used in early
experiments and shown to promote the heahng ofwound tissue.
HO
N.N
(CHS.N N =---N (CH3)2N .N
(xx).279 THE CARCINOGENIC AZO- COMPOUNDS
It is also noteworthy that the 1- and 2-naphthalene analogues of4-dimethyl-
aminoazobenzene, namely 4-dimethylaminophenylazo-I'-naphthalene (XX) and
4-dimethylaminophenylazo-2'-naphthalene (XXI), are inactive in rats (Kinosita,
1940 ; Miqer and Baumann, 1945b).
Itis,however,the uinsubstitutedazonaphthalenes whichformthemostinterest-
ing series in this group. These compounds were originaRy examined because
operatives engaged in the manufacture of naphthylamine are particularly liable
to acquire cancer of the bladder. It was thought that azonaphthalenes might
arise by mild oxidation ofthenaphthylamines, and might conceivably be present
as impurities in the commercial product.
2:2'-Azonaphthalene (VI) was found to produce liver tumours in a very large
proportion ofthe mice to which it was administered either by mouth, by gubcu-
taneous injection, or even by painting on the skin. The tumours were mostly
cholangioma, but some were hepatoma. A few tumours were also obtained
with 1:l'-azonaphthalene (VII) ; but 1:2'-azonaphthalene (VIII) was found to be
inactive (Cook, Hewett, Kennaway and Kennaway, 1940).
TABLE V.-Phenylazonaphthalene8 and Azonaphthalenie&
Carcinogenic activity.
Compound.
Refer- Refer_
HO Rats.
ences. Mice. ences.
Sudan I C' oil orange E N = N
>= 0 a + b
Sudan II, CH.3 HO
N N
`3
0 a
HO
N = N N N
Sudan III, \=/ 0 a
CH3 CH3 HO
Scarlet red, N = N N=N
0 a
H2N
YellowAB,
0 0
CH3 H2N
YeRow OB, N = N
0 c280 G. M. BADGER AND G. E. LEWIS
TABLEV.-(cont.)
Carcinogenic activity.
Compound.
Rats. Refer- Mice. Refer-
ences. ences.
(GH ) N N N
0 de
(CH3)2N N N
0 e
aa" f
N N-1
N N
0
'N = N
H N N=N-
0 f
HO
N = N-11
(Pigment Bordeaux N)
a, Hartwell, 1941. b, Kirby and Peacock, 1949. c, Badger, Cook, Hewett, Kennaway, Kennaway and Martin, 1942. d, MiRer and Baumann, 1945b. e, Kinosita, 1940. f, Cook, Hewett, Kenna-
way and Kennaway, 1940. g, Maruya, 1938.
(v) The influence ofthe azo-linkage.
This can be studied in two ways : firstlyby examining the effect of oxidation
at the azo-linkage ; and secondly by progressive replacement of the nitrogen
atomsby CH groups.
As to the first method, little has been done. It does appear, however, that
4-amino-2'.:3-dimethylazoxybenzene (XXII), the azoxy- c'ompound corresponding
to o-ammoazotoluene, is inactive in rats (Nagao, 1939). Azoxybenzene and
o-azoxytoluene (XXIII) are also inactive (Hartwell, 1941).t
Rats. Referenc'es. Mice. References.
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CH3 CH3
N.N NH2 4
0
CH3 CH3
N =--N
f
0
The replacement of the nitrogen atoms by CH produces some curious results
(Table VI). N, N-Dimethyl-N'-benzal-p-phenylenediamine (XXIV) and 4-cli-
methylaminobenzalaniline (XXV) are inactive in rats (NEller and Baumann,
1945b), but 4-diinethylaminostilbene (XXVI) has been shown to be a potent
carcinogen. In mice, however, although tumours were produced, it proved to be
muchlesspotent. Severalothercompoundsofthe sametype,mcluding2'-methyl-
4-dimethylaminostilbene anda-(4-dimethylaminophenyl)-,#-(I'-naphthyl)-ethvlene
are also potent carcinogens for the rat. Apart from sarcomas at the site of
injection, these compounds produced many cancers at a distance, including
carcinoma of the eyelid, cholangiomata of the liver, multiple mammary fibro-
adenomata in females, adenomata of the lung, and so on (Hadclow, Harris, Kon
and Roe, 1948).
CH=N N(CH3)2
(IDY)
CH=CH N(CH3)2
N=CH N(CH3)2
(Ax-v)
CH=CH
XYVTT
TABLEVI.-The, Influence ofthe Azo-linkctge.
Carcinogenic activity.
1-1-11 .&, uompouna.
//-'\\ N = N '//-\\N(CH3)2 ++ a c
--CH = N \\N(CH.,). 0 a
a // \\ N = CH-// \\N(CH3)2 0
//-\\ CH = CH N(CH3)2
- b (+) b
a, Miller and Baumann, 1945b. b, Haddow, Harris, Kon and Roe, 1948. c, Table III.
It seems therefore that thereplacement oftheazo-hnkage in4-climethylamino-
azobenzene produces a compound having less specialised carcinogenic activity.282 G. M. BADGER AND G. E. LEWIS
On the other hand, it is noteworthy that 2:2'-dinaphthylethylone (XXVII) is
completely inactive, in mice, in contrast to the striking activity of the corres-
ponding azonaphthalene towards mice livers (Badger, Cook, Hewett, Kennaway,
Kennaway and Martin, 1942).
The Effect ofDiet.
It is not proposed togive a detailed review ofthe effect of diet on the carcino-
genic activity of the azo- compounds ; but a brief account is necessary (for a
comprehensive review see Rusch, Baumann, MiUer and Kline, 1945).
Nearly aR the early work in this field was carried out in Japanese laboratories.
The usual procedure was to add a solution of the azo- compound in ohve oil to a
measured quantity of ground rice. The rats were then fed this mixture, which
was supplemented with a little carrot. Using this deficient diet, 4-dimethyl-
aminoazobenzene was found to induce liver tumours in a high percentage of the
rats used (Kinosita, 1937).
It soon transpired that the diet plays a very important role in this type of
carcinogenesis. With more balanced diets the appearance of liver tumours was
either delayed, or entirely prevented. The use of either wheat, rye or millet in
place ofrice afforded some protection ; and various substances added to the basal
diet were found to reduce the incidence of liver tumours to a marked degree. Beefliver andyeast werefound to beespecially effective in thisrespect (Nakahara,
Mori and Fujiwara, 1939 ; A-ndo, 1938 ; Sugiura and Rhoads, 1941).
These observations indicated that vitamins ofthe B group might be involved,
and tests have shown that while biotin, pyridoxine and vitamin B increase the .12 incidence of liver tumours (du Vigneaud, Spangler, Burk, Kensler, Sugiura and
Rhoads, 1942 ; Miner, Miller, Baumann and Rusch, 1943 ; Day, Payne and
Dinning, 1950), riboflavin has a markedprotective action. Thisprotective action
is greatest when the diet also contains adequate protein; nearly an the so-caRed
protective diets are rich in both riboflavin and protein (Kensler, Sugiura, Young, Halter and Rhoads, 1941 ; Miner, Nhller, Baumann and Rusch, 1943).
The protective action seems to be closely associated with the concentration
of riboflavin in the liver. Rats fed diets know-n to accelerate tumour induction
were found to have less riboflavin in the livers than controls ; and rats fed various
protective diets were found to have greater hepatic riboflavin levels than controls
(Nhller, Miller, Kline and Rusch, 1948). Moreover, certain azo- compounds markedly lower the hepatic concentration of riboflavin (Kensler, Sugiura and
Rhoads, 1940). The decrease appears to be roughly equivalent to the carcino-
genicity of the dye. Thus 3'-methyl-4-dimethylaminoazobenzene was most
effective, 4-dimethylaminoazobenzene and 4-methylaminoazobenzene were fairly effective, and 2 -methyl-4-dimethylaminoazobenzene, 4'-methyl-4-dimethylamino- azobenzene, o-aminoazotoluene and 4-aminoazobenzene and azobenzene had little
or no effect (Griffin and Baumann, 1946). Griffin and Baumann (1948) conclude
that there is an inverse relationship between the rate of tumour development and the level ofhepatic riboflavin maintained on any particular dietary regimen. Miller and Miller (1947) have found that when azo- compounds are fed to rats,
a portion of the dye becomes very tightly bound in the liver. Especially signifi-
cant was the observation that the amount of bound azo- compound found in the
livers of rats fed 4-dimethylaminoazobenzene and 4-methylaminoazobenzene on283 THE CARCINOGENIC AZO- COMPOUNDS
a low riboflavin diet was greater than that in rats fed on a high riboflavin diet.
Furthermore, the potent carcinogenic compounds gave higher levels of bound
azo-d , in a shortet time than the less active compounds (MiRer, Miller Sapp
and Weber, 1949).
In addition, Silverstone (I948) has shown that there is a direct relationship
(Table VII) between the level ofcarcinogenic dye (in this case 4-dimethylamino-
azobenzene) in the liver, and the incidence ofhver tumours.
TABLE VII.-Diet and Tumour -Incidence.
Average level of
Diet. carcinogenic azo-dye/g. Per cent incidence
of liver at 8 weeks' hopatomas at.
period. 6 months.
High protein, high fat 0
- 32 jug. 25
Brown rice, yeast 0-22 37
Low protein, high fat 0-46 58
Low protein, low fat 0.51 71
Brown rice O- 89 96
lt is reasonable to conclude therefore (i) that the greater the concentration
the carcinogen can achieve in the liver, the greater its carcinogenic activity ;
and (ii) that a high riboflavin content in the liver reduces the concentration of
carcinogen in that organ and hence reduces the tumour incidence.
The effect of the riboflavin may be to hinder the conversion of the azo-
compound into its carcinogenic derivative (possibly a protein-azo- compound
complex) ; or the riboflavin may increase the ability of the liver to detoxify the
azo- compound by converting it into simpler non-carcinogenic compounds.
Metabolism ofAzo- Compounds.
The carcinogenic azo- compounds do not, as a rule, produce tumours at the
site ofapplication in rats, but appear to have a more or less specific action on the
liver. Some of the compounds do produce tumours in the urinary bladder and
tumours at some other sites have also been observed. For example, Lowenhaupt
(1949) observed some lymphoblastic lymphosarcomas in rats bearing intrasplenic
pellets of 4-dimethylaminoazobenzene. Hoch-Ligeti (1949) obtained primary
pancreatic tumours in rats fed 4-dimethylaminoazobenzene, and it seems that
the dye can affect other organs if the liver is
" protected
" by a suitable diet.
Nevertheless, the specificity is very striking and is in marked contrast to the
carcinogenicpolycyclichydrocarbons such asbenzpyrene andmethylcholantbrene, which produce tumours at the site ofapplication.
For this reason the metabolism of the azo- compounds is of considerable
importance, and it has often been suggested that the azo- compounds are not
carcinogenic per se, but that they are converted into active substances in the
liver.
Most of the work in this field has been carried out with 4-dimethylaminoazo- benzene. This undergoes demethylation in the rat, relatively large amounts of
4-methylaminoazobenzene and 4-aminoazobenzene being recoverable (Kensler, Magill and Sugiura, 1947). Dealkylation of the diethyl- derivative also occurs
(Kensler, Magill, Sugiura and Rhoacls, 1946). It is also noteworthy that when
4-methylaminoazobenzene is administered, the liver has been found to contain284 G. M. BADGER AND G. E. LEWIS
4-aminoazobenzene and 4-dimethylaminoazobenzene as weU as the mono-methyl
compound. On the other hand, when 4-aminoazobenzene was fed, this was the
onlydyefoundinthetissues(Miller, MiUer andBaumann, 1945). Specialmethods
for the determination of these compounds have been devised by MiRer and
Baumann (1945a).
4-Dimethylaminoazobenzene also undergoes reductive fission in rats, and
p-phenylenediamine, p-aminophenol and their acetylation products have been
detected in the urine (Stevenson, Dobriner and Rhoads, 1942). p-Phenylonedia-
mine and N, N-dimethyl-p-phenylenediamine have been shown to inhibit certain
important enzyme systems, and Kensler, Dexter and Rhoads (1942) therefore
suggested that the carcinogenic activity may be due to
"spht products
" of these'
types (or to a semi-quinone free radical of similar structure). In the opinion
ofthe present reviewer thisinterestinghypothesis has now beenproved erroneous.
p-Phenylenediamine and its N, N-dimethyl- derivative have both been shown
to be devoid ofcarcinogenic activity. Moreover, there are many azo-compounds
which would be expected to yield these diamines on reductive fission, but which
are entirely inactive or have only slight activity. For example, 4'-methyl-4-
dimethylaminoazobenzene is much,less active than 4-dimethylaminoazobenzene
as acarcinogen,yet both would beexpected toyieldthe same,dianiines. Similarly,
itissurprisingthatl'-(4'-dimethylaminophenylazo)naphthaleneand2'-(4-dimethyl-
aminophenylazo)naphthaleine are both entirely inactive (Table V). Many other
examples could be given (Kirby, 1945; Crabtree, 1949; Rusch, Baumann,
Afiller and Kline, 1945). It is also significant that an amino- substituent is not
essential for activity in an azo- compound, 2:2'-azonaphthalene being a striking
example of an active carcinogen lacking such a group.
Another interesting hypothesis was put forward by Cook, Hewett, Kennaway and Kennaway (1940). It was suggested that the azo- compound may first be
reduced to the hydrazo- derivative, and subsequently Buffer the benzidine trans-
formation and loss of ammonia to form a carbazole derivative. In particular,
i
the case of2:2'-azonaphthalene (XXVIII) it was suggested that the true carcino-
gen, formed in theliver, is 3:4:5:6-dibenzcarbazole (XXXI). Thistransformation,
illustrated b the scheme (XXVIII) >(XXXI), can certainly be car.ried out
very readily in vitro, and although there is no proof that it does occur in vivo,
certain facts are.suggestive. It has been shown, forexample, that thepostulated intermediate diamine (XXX)produces liver tumours ofthe cholangiomatoustype
N = N NH-NH
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(as doestheazo-compound) ; and 3:4:5:6-dibenzcarbazolehas notonly been shown
to produce hver tumours but also tumours at the site of application (Boyland
and Brues, 1937).
Evidence of a negative nature is provided by the related 1:2'-azonaphthalene
and its transformation products. In this case the azo- compound, and the
diamine derived from it, have little or no action on the liver. This diamineyields
1:2:5:6-dibenzcarbazole by prolonged boiling with hydrocliloric acid, and this
appears to be almost without carcinogenic action on the liver (Badger, Cook,
Hewett, Kennaway, Kennaway and Martin, 1942).
Furthermore, Elson and Warren (1944) have found that when azobenzene is
administered to rats, the urine contains n'ot only aniline, but also a water-soluble
compound (probably a derivative of hydrazobenzene) which on treatment with
dilute acid is converted into benzidine. With 4-dimethylaminoazobenzene it
seems that a benzidine type ofrearrangement may take, place in vivo even more
readily than with azobenzene.
In spite of these successes, it is unfikely that this is the full story. Benzidine
rearrangement of the hydrazo- compound (XXXII) resulting from 4-dimethyl-
aminoazobenzene is know-n to give 2:4'-diamino-5-dimethylaminodiphenyI
(XXXIII) together with some semidine (XXXIV) (Jacobsen, 1922); and the
former has been shown to be inactive even when fed at ahigh level for 10 months.
(In this connection, however, it is worth remembering that 4-dimethylamino-
diphenyl produces cancer in a variety of organs in the rat (Miller, Miller, Sandin
and Brown, 1949).
N(Cti3),z N(CH3)2
NH-NH H2N
NH
The theory is not obviously applicable to other substituted azo- compounds,
especially as evenclosely related compounds oftengive differenttypes ofproducts
in the benzidine reaction. 4-Aminoazobenzene, for example, unhke the
4-dimethylamino-derivative,gives thep-semidine asthemajorproduct (Jacobsen,
1922). Furthermore, M'ller, Miller and Sapp (1951) have found that carcinogeiuc
activity can be demonstrated in various substitutedcompounds which areunlikely
toundergo therearrangement. Only one ofthefivepossible benzidine or semidine
rearrangements could possibly occur in the case of 2'A'W-trifuoro-4-dimethyl-
aminoazobenzene (which is more potent than the parent amine) ; and this lone
possibility involves a semidine rearrangement to the 2-position. The -high
activity of the 2-fluoro- derivative makes this possibility very unlikely. MiRer,
Miller and Sapp (1951) therefore maintain that although such rearrangements
may occur in the metabolism of 4-dimethylaminoazobenzene, it is doubtful if
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Chemical Constitution and Carcinogenic Activity.
Some azo- compounds are known to exist both in cis and transforms ; but the
trans form is always the more stable. All the compounds which have been
tested for carcinogenic activity appear to have been trans compounds, so that this
is the only configuration which need be considered here.
The structure of tran8 azobenzene itself has been established by analysis of
the X-ray diffraction pattern (de Lange, Robertson and Woodward, 1939). It is
flat molecule, and has the dimensions show-n in the accompanyinLr diagram
(XXXV). The C N bonds (I
-41A) are somewhat shorter than normal single
bonds of this type (1-47A); and the N=N bond (1-23A) is somewhat longer
than a normal double bond ofthis nature (1-20A). The explanation is, of course,
that the azo- group is conjugated with the aromatic rings. In other words,
structures oftype (XXXVI) contribute to the
" resonance hybrid". The C N
bonds therefore have some double bond character, and hence are shorter than
pure single bonds. Similarly, the N=N bond has some single bond character,
and hence islongerthan'a pure double bond ofthis nature. In relatedcompounds
e.g., azonaphthalenes) the character ofthe N=N bond is dependent on the extent
ofconjugatio'n with the aromatic ring systems; the greater the coniuvation, the
smaller the double bond character of the N.N bond.
1-41
ilPN N T
I-39 1 1.50 N N -41 +
It must be remembered that eachnitrogen atom has a
" lonepair ofelectrons
not involved in bond formation. These electrons are also shared with the ring
systems to some extent, so that azo- nitrogen atoms are relatively non-basic.
There is thus a certain electron density associated with the N.N linkage in
azo- compounds, this density being controRed by the extent of conjugation with
the particular aromatic ring systems involved.
Substituents can also affect this density of electrons, and it is instructive to
consider this aspect of the matter in some detail.
Substituents can be expected to modify the electron density at the N=N
linkage in two ways. In the firstplacethey maymodify the extent ofconjugation ofthe azo- group with thering systems, and either increase or decrease the double
bond character. It seems hkely, however, that such modifications are of a
niinor character, and that the electron density will be affected to a greater degree by direct transfer ofcharge to (or from) one of the nitrogen atoms.
Anelectron-donating substituent (A) in the ortho or paraposition, forexample, would increase the electron-density around the nitrogen further removed from it,
as in structure (XXXVII). Similarly, an electron'-attracting substituent (B) in
the ortho or para position would decrease the density of electrons around the
same nitrogen atom, as in structure (XXXVIII).
This is equivalent to saying that structures such as (XXXVIIa) and
(XXXV111a) contribute to the resonance hybrids of such substituted compounds
to a significant extent.THE CARCINOGENIC AZO- COMPOUNDS 287
rl;.)
B .N
(XXXVII.1)
e E)
B N -N
xviii
A -lx =ON
(xxxvii)
E) 8
A N-N
(XXMIa)
Substituents in the meta positions, however, are not conjugated with the
azo- group, and hence can affect the electron demity only by virtue of their
inductive effects. In this case, the nearer nitrogen atom wiR be more affected,
as in structure (XXXIX).
B
N
(xxxix)
These effects of substituents are of importance because Punman (1946 ; see
also Pullman and PuRman, 1946) has suggested that carcinogeme activit in this
type of compound is to be associated with a certain critical density of electrons
on the azo-linkage (called the K' position). This hypothesis is analogous to that
for the polycyclic aromatic hydrocarbons, which associates carcinogenic activity
with a critical electron density on the phenanthrone-type double bond, caued
the K position (Pullman and Pullman, 1946 ; Pullman, 1947 ; Badger, 1948).
PuRman (1947) divides the azo- compounds into three groups:
(a) Those compounds which are inactive or only shghtly active by virtue of
an insufficient electrondensity on the K' region. This group includes compounds
such as the anils (XL and XLI), 4-aminoazobenzene (XLII), and 4-diethylamino-
azobenzene (XLIII).
CH=N N(CH3),Z
(XL)
N.N NH,2
(XLII)
N-CH N(CH3)2
(XLI)
N.N N(C2H5)2
(XLIII)
(b) This group includes the active compounds, that is, those substances
having an electron density at the K' position within the postulated upper and
lower limits. Some examples are o-aminoazotoluene (XLIV), 4-dimethylamino-
azobenzene (XLV), and 3'-methyl-4-dimethylaminoazobenzene (XLVI).288 G. M. BADGER AND G. E. LEWIS
CH3 CH3
N =---N NH2 N.N N(CH3)2
(XLIV) (XLV),
CH3
N=N N(CH3).2
(XLVI)
(e) The thi-rd group includes those which are only sfightly active or inactive,
by virtue of their excessive electron density at the K' position. Derivatives of
4-climethylaminoazobenzene with a methyl group in one of the ortho or Para
positions (e.g., XLVII, XLVIII and XLIX) fall into this class.
ICH3
N.N N(CH3)., CH3 N N N(CH3).2
(XLVII) (XLVIII)
CH3
N.N N(CH3),2
(XLIX)
Unfortunately the available data atpresent are too few for areallysatisfactory
examination of this interesting hypothesis. Very few azo- compounds having
electron-donating substituents other than alkylamino- groups have yet been
examined; and the testing of a further series of unsubstituted compounds such
as the phenylazonaphthalenes, azophenanthrenes, and so on, would also be of
value.
The evaluation of the electron density at the K' position by experimental
methods is also necessary before any satisfactory comparison between electron
density and carcinogenic activity can be made.
Hamon (1947) has studied the rates of hydrogenation of various azo-
compounds; but unfortunately this is not a very satisfactory method for the
determination of electron densities at the K' position. As she pointed out, every
substituent in the azobenzene molecule, besides having an effect on the benzene
ring, the other substituents, and on the azo-linkage, can also have an effect on
the catalyst (in this case Raney nickel). In addition, there is the possibility that
the reduction products of the different azo- compounds may poison the catalyst
to varying degrees, and this retarding influence on the rate of reduction may
vary from one azo- compound to another.
In a recent attempt to assess the influence of substituents, Rogers, Campbefl
and Maatman (1951) have determined the ionisation constants of some 4'-sub-
stituted 4-dimethylaminoazobenzenes. It seems that the first proton is added
to an azo-nitrogen and the second to the dimethylamino-nitrogen. The first and
second pKa values were determined, and the results inclicate that the greater the
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(i.e., the stronger thebasicity ofthecompound). The effect ofthe V-substituents
on the proton affinity of the azo-nitrogen atoms was found to be in the same
order as the net electron affinities of the groups as measured by Hammett's
substituent constant, (Hammett, 1940).
This means that in a series of azobenzenes, the electr'on densities at the K'
position must be directly related to the substituent constants of the substituents.
It should bepossible, therefore, to examine thevahdity ofthe PuUmanhypothesis
by comparing the carcinogenic activities of, say, a series of 3'- and 4'- substituted
4-dimethylaminoazobenzenes with the substituent constants of the substituents.
This is done in TableVIII, wherethecompounds arearranged in orderofincreasing
basicity (increasingprotonaffinity). Too fewcompounds ofthis nature have been
tested for any supposed correlation to be ofsignificance; but at least it may be
said that the available results do support thesuggestion that activity is associated
with an optimum electron density (or proton affinity) at the K' position. The
3 -ethoxy- and 4'-chloro- compounds are less active than might be predicted,
but otherwise th& correlation is as good as could be expected. (Of course, many
other factors such as the rate of metabolic deto'xication, etc. etc., may also be
involved.)
It is notpossible to extend this treatment. to the 2'- or 2-substitutedcompounds
as steric factors are ofimportance with such
" ortho
" derivatives, and no O- values
can be det-ermined. Similarl , substituents in the 3-position would be expected y
to interfere sterically with the dimethylamino- group,. and such compounds
cannot therefore provide any information of value for the present purpose.
TABLE VIII.-Substituent Constants and Carcinogenic Activities of some
1 4-substituted 4-Dimethylaminoazobenzene8.
Substituent Carc'mogenic Substituent. constant, cr. activity (rats).
4'-Nitro- + 778 0
3'-Nitro- . + 710 + +
T-Chloro- + 373 + +
W-Fluoro- + 337 + + +
4'-Chloro- + 227 +
3'-Ethoxy- + -15
4'-Fluoro- + -062 + + +
Parent compound -000 ++
W-Methyl- -069 + + +
3':5'-Dimethyl- -138 0
4'-Methyl- -170
It should also be possible to examine the validity of the Pullman hypothesis
by studying the rate of addition of electrophilic reagents to the K' r.-,gion in a
series of carcinogenic and related non-carcinogenic azo- compounds. Other
things being equal, the greater the electron density at the nitrogen atoms, the
greater the reactivity towards electrophilic reagents. -The peracids are known
to be electrophihc reagents (Swern, 1947), and perbenzoic acid- has therefore
been used against a series of substituted azobenzenes, and azona hthalenes
Badger and Lewis'1951 ; Badger and Lewis, 1952, unpublished results). The
reaction was shown to be bimolecular and may therefore be represented by the
equation
R-N.N-R + Ph-CO3H R-N.N-R + Ph-CO2H
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Azobenzene, for example, gave azoxybenzene, and azonaphthalenes gave azoxy-
naphthalenes.
Among the non-substituted compounds, the different reaction rates must
depend on the fact that the azo- group is not always conjugated with an aromatic
ring to the same extent. As ex 'ected, and in agreement with the Pullman
hypothegis, electron-releasing subtituents increase the reaction rate, and electron-
attracting substituents retard the reaction (Table IX). Forexample, 4-methoxy-
azobenzene reacts much more rapidly with perbenzoic acid than azobenzene, and
4-carbethoxyazobenzene reacts more slowly than the unsubstituted compound.
Halogenated azobenzenes also react more slowly than azobenzene itself, the
inhibitory effect of a halogen in the 4- position being CI>Br>F.
TABLE IX.-Rate8 of Reaction ofPerbenzoic Acid with Azobenzene and Related
Compound8, at 25'.
Compound.
Pveaction rate
103k2250
Azobenzene 13-9
4-Fluoroazobenzene 9-7
4-Chloroazobenzene 7-5
4-Bromoazobenzene 9-2
4_Methoxyazobenzene 58
I-Phonylazonaphthalene 14-5
2-Phenylazonaphthalene 14-5
1:l'-Azonaphthalene 2-5
1:2'-Azonaphthalone 17-7
2:2'-Azonaphthalone 17-6
In conclusion, although it seems impossible at present to come to any very
definite decisioias, recent work has been encouraging, and there is Ettle doubt
that future research will yield significant results on the relationship between
ch-emical constitution and carcinogenic activity in this class ofcompound.
SUMMARY.
1. Many derivatives of azobenzene produce cancer of the hver when adminis-
tered to rats and mice on a restricted diet.
2. The diet must be low in riboflavin and in protein.
3. Most ofthe active compounds are amio'-, methylamino- ordimethylamino-
derivatives of azobenzenes ; but an amino- group is not essential for activity of
this nature (e.g., 2:2'-azonaphthalene).
4. Additional substituents have variable effects depending on their nature
and position.
5. The hypothesis that carcinogenic activity in this series is associated with
an optimum density of electrons at the N.N- linkage is supported by recent
experimental work ; but further research is necessary before any definite con-
clusions can be drawn.
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